BRITTANY BABIAK: Open Payments
NPI 1568864353 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 26 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $696 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $140 |
| GENZYME CORPORATION | 2 | $69 |
| Amgen Inc. | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $32 |
| LEO Pharma Inc. | 1 | $32 |
| Organon LLC | 2 | $21 |
| Journey Medical Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, Zoryve, RINVOQ, Odomzo, ADBRY, COSENTYX.
Industry payments across MI — which companies pay providers there.
